Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

(2020) Wassim Abida et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

(2020) Maha Hussain et al.   NEW ENGLAND JOURNAL OF MEDICINE

PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer

(2019) Elena Castro et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA2 and Other DDR Genes in Prostate Cancer

(2019) Paz Nombela et al.   Cancers

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines

(2019) Piper Nicolosi et al.   JAMA Oncology

Tumour lineage shapes BRCA-mediated phenotypes

(2019) Philip Jonsson et al.   NATURE

Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups

(2019) Geert J.L.H. van Leenders et al.   EUROPEAN UROLOGY

Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

(2019) Hemamali Samaratunga et al.   PATHOLOGY

Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer

(2018) Pedro Isaacsson Velho et al.   PROSTATE

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations

(2018) Emmanuel S. Antonarakis et al.   EUROPEAN UROLOGY

Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

(2018) Habiba Elfandy et al.   MOLECULAR CANCER RESEARCH

Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories

(2017) Laura H. Porter et al.   EUROPEAN UROLOGY

A Prostate Cancer “ Nimbosus ”: Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies

(2017) Melvin L.K. Chua et al.   EUROPEAN UROLOGY

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories

(2017) Renea A. Taylor et al.   Nature Communications

Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH

(2016) Tamara L Lotan et al.   MODERN PATHOLOGY

Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy

(2016) Charlotte F Kweldam et al.   MODERN PATHOLOGY

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

(2016) Colin C. Pritchard et al.   NEW ENGLAND JOURNAL OF MEDICINE

High burden of copy number alterations andc-MYCamplification in prostate cancer fromBRCA2germline mutation carriers

(2015) E. Castro et al.   ANNALS OF ONCOLOGY

Integrative Clinical Genomics of Advanced Prostate Cancer

(2015) Dan Robinson et al.   CELL

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

(2015) Gail P. Risbridger et al.   EUROPEAN UROLOGY

Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer

(2014) Charlotte F Kweldam et al.   MODERN PATHOLOGY

Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer

(2012) Alison H M Reid et al.   MODERN PATHOLOGY

Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia

(2012) Tamara L Lotan et al.   MODERN PATHOLOGY